Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Janku

Showing results (51-60 of 277) with videos related to

Pageof 28
Sort By:
JCO Precision Oncology|September 11, 2020
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center StudyAnita Chawla, Filip Janku, Jennifer J Wheler, et al.
BMC Cancer|May 30, 2015
Multiple gene aberrations and breast cancer: lessons from super-respondersJennifer J Wheler, Johnique T Atkins, Filip Janku, et al.
Oncoscience|August 6, 2015
Challenges and perspective of drug repurposing strategies in early phase clinical trialsShumei Kato, Stacy L Moulder, Naoto T Ueno, et al.
Plos One|November 1, 2011
BRAF mutations in advanced cancers: clinical characteristics and outcomesHazem El-Osta, Gerald Falchook, Apostolia Tsimberidou, et al.
Molecular Cancer Therapeutics|April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare CancersRoman Groisberg, David S Hong, Jason Roszik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancerChristian Dittrich, Lubos Petruzelka, Pavel Vodvarka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Biomarker-directed therapy of squamous carcinomas of the head and neck: targeting PI3K/PTEN/mTOR pathwayFloyd Christopher Holsinger, Sarina Anne Piha-Paul, Filip Janku, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2004
Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized studyPetr Zatloukal, Lubos Petruzelka, Milada Zemanova, et al.
Oncotarget|March 28, 2020
Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN lossNicci Owusu-Brackett, Ming Zhao, Argun Akcakanat, et al.
Oncoscience|January 17, 2015
A framework for genomic biomarker actionability and its use in clinical decision makingSmruti J Vidwans, Michelle L Turski, Filip Janku, et al.
Pageof 28

Showing results (51-60 of 277) with videos related to

Sort By:
Pageof 28
JCO Precision Oncology|September 11, 2020
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center StudyAnita Chawla, Filip Janku, Jennifer J Wheler, et al.
BMC Cancer|May 30, 2015
Multiple gene aberrations and breast cancer: lessons from super-respondersJennifer J Wheler, Johnique T Atkins, Filip Janku, et al.
Oncoscience|August 6, 2015
Challenges and perspective of drug repurposing strategies in early phase clinical trialsShumei Kato, Stacy L Moulder, Naoto T Ueno, et al.
Plos One|November 1, 2011
BRAF mutations in advanced cancers: clinical characteristics and outcomesHazem El-Osta, Gerald Falchook, Apostolia Tsimberidou, et al.
Molecular Cancer Therapeutics|April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare CancersRoman Groisberg, David S Hong, Jason Roszik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancerChristian Dittrich, Lubos Petruzelka, Pavel Vodvarka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Biomarker-directed therapy of squamous carcinomas of the head and neck: targeting PI3K/PTEN/mTOR pathwayFloyd Christopher Holsinger, Sarina Anne Piha-Paul, Filip Janku, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2004
Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized studyPetr Zatloukal, Lubos Petruzelka, Milada Zemanova, et al.
Oncotarget|March 28, 2020
Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN lossNicci Owusu-Brackett, Ming Zhao, Argun Akcakanat, et al.
Oncoscience|January 17, 2015
A framework for genomic biomarker actionability and its use in clinical decision makingSmruti J Vidwans, Michelle L Turski, Filip Janku, et al.
Pageof 28